Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
6.18
+0.07 (1.15%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Inogen Revenue
In the year 2025, Inogen had annual revenue of $348.67M with 3.86% growth. Inogen had revenue of $81.72M in the quarter ending December 31, 2025, with 2.05% growth.
Revenue (ttm)
$348.67M
Revenue Growth
+3.86%
P/S Ratio
0.48
Revenue / Employee
$463,039
Employees
753
Market Cap
168.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 348.67M | 12.96M | 3.86% |
| Dec 31, 2024 | 335.71M | 20.05M | 6.35% |
| Dec 31, 2023 | 315.66M | -61.58M | -16.32% |
| Dec 31, 2022 | 377.24M | 19.24M | 5.37% |
| Dec 31, 2021 | 358.00M | 49.52M | 16.05% |
| Dec 31, 2020 | 308.49M | -53.46M | -14.77% |
| Dec 31, 2019 | 361.94M | 3.83M | 1.07% |
| Dec 31, 2018 | 358.11M | 108.67M | 43.57% |
| Dec 31, 2017 | 249.44M | 46.61M | 22.98% |
| Dec 31, 2016 | 202.83M | 43.82M | 27.56% |
| Dec 31, 2015 | 159.01M | 46.47M | 41.29% |
| Dec 31, 2014 | 112.54M | 37.09M | 49.17% |
| Dec 31, 2013 | 75.44M | 26.87M | 55.31% |
| Dec 31, 2012 | 48.58M | 17.94M | 58.57% |
| Dec 31, 2011 | 30.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Owlet | 105.71M |
| Sight Sciences | 77.36M |
| Electromed | 68.86M |
| 908 Devices | 56.20M |
| Apyx Medical | 52.84M |
| SANUWAVE Health | 44.05M |
INGN News
- 14 hours ago - Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 1 day ago - Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 1 day ago - Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth - Business Wire
- 26 days ago - Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum - Business Wire
- 5 weeks ago - Inogen, Inc. (INGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook - Business Wire
- 5 weeks ago - Inogen Announces $30 Million Share Repurchase Program - Business Wire
- 2 months ago - Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025 - Business Wire